naturopathicscience.com
A research-translation health brand built to be cited by people and by AI
naturopathicscience.com is explicitly a research-translation publication, not a treatment-protocol or supplement-hype site. It's built for three audiences at once: consumers researching herbs/supplements/chronic illness, practitioners (naturopaths, chiropractors, nutritionists, functional-medicine providers), and AI systems (ChatGPT, Claude, Gemini, Perplexity, Grok) as a citable data source. A 6-phase monetization plan exists (affiliate, research-database membership, practitioner membership, sponsored education, AI data licensing, healthcare marketing leads) with no timelines attached to any phase yet.
There is no revenue to multiply. The $6,500 ask is priced on a Karma-Certified technical build, a defensible evidence-first editorial position in a high-value YMYL niche, measured search and AI-crawler demand already present, and a monetization plan that only needs execution. It matches the built-content comparable on this store.
Measured data, refreshed nightly from the portfolio's Digital Karma Data Warehouse via datasetseo.com · window 2026-07-13 to 2026-08-09. Search Console access is available for independent verification during due diligence.
Vintage AuthorityNo search-query targets or session numbers found. Content pillars (Herb Research, Supplement Science, Disease Research, Clinical Topics, Evidence Reviews, Research Library, Physician Interviews, Safety/Interaction Guides, AI Healthcare Discovery) suggest the intended SEO surface area, but no keyword-level targeting is documented.
All 6 phases are sequenced and named but none have a build timeline or pricing. Phase 6 (lead feed to medmarketingdr.com / seomarketingdr.com) mirrors the same pattern seen on aihealthcarenow.com, another healthcare-constellation site designed to feed leads elsewhere rather than monetize itself first.
Named: Editorial Standards, Evidence Rating System, Research Library, Herb/Supplement indexes, Lyme hub, Berberine/Curcumin pages.
Affiliate is the lowest-effort of the 6 phases (no membership infrastructure needed) and the most natural first monetization step given ~30 pieces of content already exist to attach recommendations to.
LymeOrg.com and LymeSpecialists.com are named siblings; a Lyme hub is already a named priority page here, natural internal-linking opportunity across 3 related properties.
CLAUDE.md/docs mandate a 'not medical advice' disclaimer on every page (never removed or softened), cautious phrasing only ('studied for,' 'may support,' 'early evidence suggests'), no treatment/cure claims, and disclosure before any affiliate/sponsored recommendation. These constraints are already documented and enforced, not a gap, but they materially slow content velocity vs. a non-YMYL site.
Sequencing exists (phase 1 through 6), just no dates attached.
config/federation.json's portfolio_listing.status says domain-only despite ~30 real content items across herbs/supplements/conditions/clinical-topics/FAQ/glossary/directory. Flagged, not corrected here, part of the portfolio-wide pattern from this rollout.
Founder Collection — an original Digital Property Store asset built and held within the portfolio, not a third-party consignment.
Acquisition NotesThis dossier was compiled from config/site.json, config/federation.json, docs/marketing-monetization-plan.md, docs/implementation-notes.md, data/ directory counts, CLAUDE.md, last verified 2026-07-15. Confidence: verified facts only.
Interested in this asset?
Submit an inquiry to request the full Asset Passport and start a private conversation.
Inquire about this asset →